Abstract: The invention relates to a method for continuously producing plastic tubes by biaxial drawing consisting in producing a blank (E) by extrusion, heating said blank to a molecular condensation temperature, radially dilating it by the internal pressure of a fluid applied between two axially distant obturator rings (7, 11) and in carrying out a calibration (8) and cooling (9) associated with an axial tension produced on a tube at the output thereof. A pressure opposite to the internal pressure is applied to the blank wall from the outside in at least one area which is exposed to the radial dilation. Said opposite pressure is selected such that it is lower than the internal pressure, thereby preventing a counteraction to said dilation and remaining sufficient in order to control the dilation growth in such a way that it is possible to ensure a substantially constant material thickness on the same circumference.

Abstract: Highly dense shaped parts are produced with a powder metallurgic process. The parts are formed of an alloy that, besides of at least 20 weight % chromium, consists of iron and one or several additional alloy portions that in sum do not amount to more than 10 weight %. The part is produced by pressing and sintering to near final shape a ready-to-press powder where the additional alloy portions are introduced in form of a master-alloy powder. The master-alloy may contain the following variations: the additional alloy portions and the iron portions; or the additional alloy portions, the iron parts, and the chromium portions; or additional alloy portions and the chromium portions.

Abstract: A microfluidic component having a microfluidic channel is joined to an array component having a flexible array substrate. In an embodiment, the array component includes a prefabricated flexible array that couples with the microfluidic component in modular fashion. The modular architecture provides for different combinations of microfluidic components and array components that can be used to create customized processing and analysis tools.

Abstract: Briefly, the present invention provides a system and method for high throughput processing using sample holders. The system has a plurality of work perimeters, with a rotational robot preferably associated with each work perimeter. At least one transfer station area is provided between adjacent work perimeters to facilitate robotic transfer of sample holders from one work perimeter to another area. Each work perimeter typically includes a plurality of defined station locations, with each station location positioned to be accessible by the robot associated with that area. In addition, each station location is typically configured to receive a device, such as an automated instrument or a holding nest. Device components are arranged at selected station locations according to specific application requirements to provide a flexible, robust, reliable, and accurate high throughput processing system.

Abstract: An apparatus for high-throughput combinatorial syntheses of organic molecules including a reaction vessel for containing a combinatorial-chemistry synthetic reaction, a liquid dispenser for dispensing the liquid, a liquid aspirator and an adjustment mechanism. The reaction vessel includes an ingress aperture allowing a liquid to enter into an interior of the vessel and an egress aperture for aspirating the liquid from the vessel. The liquid dispenser dispenses liquid through the ingress aperture. The liquid aspirator aspirates liquid through the egress aperture and includes a rotor for carrying the vessel and orbiting the vessel about an axis of rotation. The rotor is oriented generally in a horizontal plane and includes an adjustment mechanism for adjusting the angle of the vessel relative to the horizontal plane in response to the centrifugal force generated by orbiting the vessel about the axis of rotation. A method of combinatorial synthesis of organic molecules is also disclosed.

Abstract: In reagent reaction experiments using microplates, a desired period of time can be set for determining the time to introduce a reaction stop solution after introduction of a reagent. The set time is measured starting from the introduction of the reagent and the reaction stop solution is introduced immediately after expiration of the set time. A control device for an automatic liquid handling system having the above-described reaction time managing feature is also provided with a self-diagnosing function that is capable of determining whether scheduled processes are executable or not during the time set before execution of the processes and informing an operator of the results of determination.

Abstract: The present invention relates to a sensor for detecting chemical, biological, biochemical or other environmental stimuli, and includes a plurality of colloidal particles having chemical receptors bound to each particle's surface, wherein when a target stimulus is directed to the bound chemical receptor, the gelled matrix contracts or expands, which changes the lattice constant, thereby changing the pattern of diffracted light in a measurable manner so that the target stimulus' presence can be detected by a spectrometer. The plurality of colloidal particles are composed of a material having a first dielectric constant, and the gel and surrounding medium have a second dielectric constant. The colloidal particles can be assembled using holographic optical tweezers and polymerized to create an integrated sensor array, which diffracts light in a detectable characteristic manner.

Abstract: The present invention provides ratiometric fluorescent pH sensors for non-invasive, continuous monitoring of pH in such applications as fermentation processes. The ratiometric fluorescent pH sensors comprise a fluorescent dye that exhibits a shift in excitation wavelength with a corresponding shift in pH in the local environment of said fluorescent dye. Ratiometric measurements of the emission intensities at dual excitation maxima correlate to pH. Also provided is a fluorescent dye 6-methacryloyl-8-hydroxy-1,3-pyrene disulfonic acid (MA-HPDS). Further provided are systems and methods to non-invasively and continuously monitor pH.

Abstract: A biological assay device for use in molecular biology, pharmaceutical research, genomic analysis, combinatorial chemistry, and in the general field of the analysis of molecules that may be deposited on supports of various kinds is provided. Specifically, the present invention includes a fluidic or microfluidic device, which integrates fluidic capability into existing multi-well plates of standard configuration, for performing either single or continuous fluidic manipulations in a high-throughout format. Methods for the use and manufacture of these devices are also provided.

Abstract: A fluidic circuit for receiving a fluid and separating a component of a fluid from the fluid comprises a separation chamber for receiving the fluid, an air chamber in fluid communication with the separation chamber, and a return channel in fluid communication with the separation chamber. In an advantageous embodiment, the fluidic circuit is subjected to a force, such as a centrifugal force, so that substantially all of the component of the fluid is moved to the return channel while substantially all remaining portions of the fluid are moved to the separation chamber.

Abstract: A system and a method to detect biological and chemical agents in a sealed contained at, for example, a mail-processing center. The system includes filtration and vacuum subsystems cooperatively working to draw an air sample from the interior of the particulate containment system for evaluation by a biosensor or chemical analyzer to detect the presence of a contaminant. The vacuum subsystem includes a vacuum generator, flow meters, and pressure regulators to accommodate the varying volume within the particulate containment system. The filtration system includes an inlet filter and a high efficiency particle air filter (HEPA) filter. The inlet filter removes coarse impurities, such as dust and dirt, from the incoming air to improve sensor efficiency. The HEPA removes contaminants from the air sample prior to being released to the surrounding environment, thereby eliminating the possibility of spreading the contamination outside the particulate containment system.

Abstract: Methods and apparatus for the production of low sodium lithium carbonate and lithium chloride from a brine concentrated to about 6.0 wt % lithium are disclosed. Methods and apparatus for direct recovery of technical grade lithium chloride from the concentrated brine are also disclosed.

Abstract: The present invention relates to an apparatus and method suitable for dispensing heterogeneous compositions.

Abstract: The invention relates to a method for the stabilization of the production capacity of an extraction plant extracting metals in a process, where the metal content of the feed solution varies. For the stabilization of capacity, the extraction cells and their piping are constructed and situated in such a way, that the extraction stages can be connected in different combinations, either in parallel or in a series. The method is especially suitable for the copper extraction process.

Abstract: The present invention discloses a method for reducing NOx in exhaust gases of an internal combustion engine. The purpose of this invention is to convert engine out NOx (approximately 90% NO in diesel exhaust) into roughly a 50:50 mixture of NO and NO2, while simultaneously oxidizing engine-out hydrocarbons which interfere with the reduction of NOx by urea or ammonia. The present invention demonstrates that a 50:50 blend of NO and NO2 is reduced more rapidly and with higher efficiency than a gas stream which is predominantly NO. In addition, catalyst in an engine exhaust that is a 50:50 mixture of NO and NO2 is far more resistant to hydrothermal deterioration than using NO alone. In another embodiment of the present invention, a vehicle exhaust system utilizing the method of the present invention is provided.

Abstract: Processes for selectively removing sulfur-containing compounds from a gas are described herein. The processes generally include contacting a first gas including carbon dioxide and hydrogen sulfide with a scrub solution including ammonium bisulfite and ammonium sulfite in a first contact zone to produce a first contact zone effluent liquid including ammonium thiosulfate and a first contact zone overhead gas including carbon dioxide.

Abstract: An exhaust gas treatment apparatus (20) for reducing the concentration of NOx, HC and CO in an exhaust gas stream (18) such as produced by a gas turbine engine (12) of a power generating station (10). The treatment apparatus includes a multifunction catalytic element (26) having an upstream reducing-only portion (28) and a downstream reducing-plus-oxidizing portion (30) that is located downstream of an ammonia injection apparatus (24). The selective catalytic reduction (SCR) of NOx is promoted in the upstream portion of the catalytic element by the injection of ammonia in excess of the stoichiometric concentration, with the resulting ammonia slip being oxidized in the downstream portion of the catalytic element. Any additional NOx generated by the oxidation of the ammonia is further reduced in the downstream portion before being passed to the atmosphere (22).

Abstract: A low cost and scalable processes for producing nanostructured LiFexM1-xPO4 and nanostructured LiFexM1-xPO4/C composite powders, where 1?x?0.1 and M is a metal cation, such as Mn, Co, Ni, and V. Electronics made of either nanostructured LiFexM1-xPO4 powders or nanostructured LiFexM1-xPO4/C composite powders exhibit good electrochemical properties. The electronic conductivity of nanostructured LiFexM1-xPO4 powders is enhanced by intimately mixing them with ultrafine carbon particles. Thus, the use of nanostructured LiFexM1-xPO4/C composite powders will lead to high power density, low cost and environmentally friendly rechargeable Li-ion batteries.

Abstract: Processes for producing fine LiFePO4/C and nanostructured LiFexM1?xPO4/C composite powders, where 1?x?0.1 and M is a metal cation. Electrodes made of either nanostructured LiFexM1?xPO4 powders or nanostructured LiFexM1?xPO4/C composite powders exhibit excellent electrochemical properties. That will provide high power density, low cost and environmentally friendly rechargeable Li-ion batteries.

Abstract: Conventional porous carbon materials obtained by carbonizing an organic gel were prone to shrinkage during their manufacture, in the course of which the density rose and the specific surface area decreased. Another problem was that density and specific surface area were difficult to control after an organic gel had already been formed. In the present invention, a carbon material with a large specific surface area is formed by forming a composite porous material having a reticulated skeleton and composed of a dry gel of an inorganic oxide, and taking advantage of the reaction of this dry gel of an inorganic oxide as a structural support. In one method, a carbon material is formed in this reticulated skeleton in a state in which the characteristics of a dry gel of an inorganic oxide with a large specific surface area are maintained.

Abstract: A process for continuously producing carbon fibers in a vapor phase by causing a carbon compound to contact a catalyst and/or a catalyst precursor compound in a heating zone. In this process, the carbon compound, the catalyst precursor compound and an additional component are supplied to the heating zone, and these components are subjected to a reaction under a reaction condition such that at least a portion of the additional component is present as a solid or liquid in the heating zone.

Abstract: A carbon fiber paper manufacturing process and construction has oxidized fiber as raw material needle punched into a construction of 0.1˜20 mm thick, 5˜500 g/m2 oxidized fiber felt of weight, then impregnated in high density epoxy, hot compressed and hardened, then finally carbonization processed at temperature range of 700˜3000° C. to yield porous carbon fiber paper with high resilience, low porosity, and flexure, and low surface resistance to be used as the substrate of porous carbon electrode in fuel battery.

Abstract: This invention relates generally to a fullerene nanotube composition. The fullerene nanotubes may be in the form of a felt, such as a bucky paper. Optionally, the fullerene nanotubes may be derivatized with one or more functional groups. Devices employing the fullerene nanotubes of this invention are also disclosed.

Abstract: A two step method to increase the thickness of human hair in which in Step I, a high pH priming lotion is applied to pre-treat the hair to increase its pH, create an anionic charge and therefore loosen and lift the cuticle layers of the hair. In Step II, an acidic thickening composition is applied on top of the Step I composition to deliver polymers and conditioning ingredients to the hair's polypeptide molecule sites. The Step II components have cationic sites that chemically bond to anionic groups in the hair, making them substantive to the hair wherein they deposit under and around the crevices of the cuticles. The low pH of Step II tightly closes the cuticles, sealing the substantive ingredients to the surface of the hair, providing the hair with increased diameter and long lasting thickness.

Abstract: Hydrophilic polyquaternary polyorganosiloxane copolymers and their use as wash-resistant hydrophilic softeners.

Abstract: The entomopathogenic fungus Paecilomyces fumosoroseus and certain related species, such as P. javanicus are useful for controlling infestations by subterranean termites, particularly those belonging to the family Rhinotermitidae. The family Rhinotermitidae includes two species of subterranean termites having extremely high economic importance in the United States; namely the Formosan subterranean termite (Coptotermes formosanus Shiraki), and the native (North American) subterranean termite (Reticulitermes flavipes). Large numbers of infectious propagules of the fungus, such as blastospores and conidia can be readily cultured on media that are easily and inexpensively prepared and incorporated into formulations for controlling termites. These fungi are useful for protecting living trees, plants, wood, wood structures, and other cellulosic materials susceptible to termite infestation and damage.

Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.

Abstract: The present invention provides a pharmaceutical preparation for hearing impairment, which is suitable for gene therapy of hearing impairment, that is, a pharmaceutical preparation for hearing impairment which comprises a virus envelope vector encapsulating a hepatocyte growth factor (HGF) gene or its plasmid as an active ingredient. Particularly, it is suitable as a pharmaceutical preparation for gene therapy for the purpose of prevention and treatment of deafness.

Abstract: The present invention provides a universal immunomodulatory cytokine-expressing bystander cell line, a composition comprising such a cell line and a cancer antigen, a method of making such a cell line, and a method of using such a composition.

Abstract: Cells present in processed lipoaspirate tissue are used to treat patients. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Compositions that are administered to a patient include a mixture of adipose tissue and stem cells so that the composition has a higher concentration of stem cells than when the adipose tissue was removed from the patient.

Abstract: The present invention provides for design and therapeutic use of ADPase enhanced polypeptides, pharmaceutical compositions, and methods useful for preventing and reversing platelet aggregation and recruitment for the treatment and prevention of vascular disorders in mammals.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: Disclosed are chimeric HPV L1 proteins and virus like particles comprising the same which are capable of generating high titer neutralizing antibody responses against at least two HPV types. The disclosed chimeric HPV L1 proteins and VLPs are useful as therapeutic and prophylactic reagents, as well as reagents for diagnosing papillomavirus infection.

Abstract: The present invention relates generally to methods and compositions for targeting, delivering, and activating platelet-dependent vascular occlusion agents. In particular, antibodies carrying platelet binding agents are targeted to hyperplastic cells or tissues, such as the vasculature of solid tumor masses; the platelet binding agent then binds and activates platelets, which in turn bind and activate other platelets. This process results in the formation of a platelet-mediated thrombus-causing vessel occlusion.

Abstract: The present invention relates to a monoclonal antibody binding specifically to the p60 protein of Listeria monocytogenes, a hybridoma cell producing the monoclonal antibody, a test kit comprising the monoclonal antibody, and a method for detecting Listeria monocytogenes using the monoclonal antibody. The inventive monoclonal selectively recognizes only Listeria monocytogenes, so that the use of such an antibody allows for rapid determination of the food contamination with these bacteria pathogenic to humans.

Abstract: There are provided uses of an antibody directed to CX3CR1 and fractalkine. Killer lymphocytes can be readily identified, eliminated and separated by using an anti-CX3CR1 antibody. Further, there can be provided an antibody drug for suppressing chemotaxis and cytotoxic activity of killer lymphocytes by suppressing an interaction between CX3CR1 and fractalkine.

Abstract: Midkine (MK), which is a retinoic acid-inducible heparin-binding growth factor, enhances neutrophilic migration and exists in an inflammatory state at a high concentration. The midkine or its inhibitors can be used for treating neutrophilic functional disorders or inflammatory diseases.

Abstract: The present invention provides vaccines and methods for making the vaccines that actively or passively protect an equid or other animal against Sarcocystis neurona. In particular, the present invention provides vaccines that provide active immunity which comprise a polypeptide or DNA vaccine that contains or expresses at least one epitope of an antigen that has an amino acid sequence substantially similar to a unique 16 (±4) kDa antigen and/or 30 (±4) kDa antigen of Sarcocystis neurona. The present invention further provides a vaccine that provides passive immunity to Sarcocystis neurona comprising polyclonal or monoclonal antibodies against at least one epitope of an antigen substantially similar to a unique 16 (±4) kDa antigen and/or 30 (±4) kDa antigen of Sarcocystis neurona.

Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.

Abstract: The genome sequences and the nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells and animals transformed by the vectors are provided. Methods for detecting the nucleic acids or polypeptides, and kits for diagnosing infection by a PWD circovirus, also are provided. Method for selecting compounds capable of modulating the viral infection are further provided. Pharmaceutical, including vaccine, compositions for preventing and/or treating viral infections caused by PWD circovirus and the use of vectors for preventing and/or treating diseases also are provided.

Abstract: Neuroinvasive and neurovirulent strain of the West Nile virus, named IS-98-ST1, nucleic acid molecules derived from its genome, proteins and peptides encoded by said nucleic acid molecules, and uses thereof.

Abstract: Methods for treating a hand washing disorder by local administration of a Clostridial toxin. The local administration can be by intramuscular, transdermal, intradermal or subdermal administration of a low dose of botulinum toxin.

Abstract: Provided herein is a PEA polymer blend and coatings or implantable devices formed therefrom. The PEA polymer blend is formed of a PEA polymer and a material capable of hydrogen bonding with the PEA. The PEA polymer blend can form a coating on an implantable device, one example of which is a stent. The coating can optionally include a biobeneficial material and/or optionally with a bioactive agent. The implantable device can be used to treat or prevent a disorder such as one of atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, and combinations thereof.

Abstract: A porous ?-tricalcium phosphate material for bone implantation is provided. The multiple pores in the porous TCP body are separate discrete voids and are not interconnected. The pore size diameter is in the range of 20-500 ?m, preferably 50-125 ?m. The porous ?-TCP material provides a carrier matrix for bioactive agents and can form a moldable putty composition upon the addition of a binder. Preferably, the bioactive agent is encapsulated in a biodegradable agent. The invention provides a kit and an implant device comprising the porous ?-TCP, and a bioactive agent and a binder. The invention also provides an implantable prosthetic device comprising a prosthetic implant having a surface region, a porous ?-TCP material disposed on the surface region and optionally comprising at least a bioactive agent or a binder. Methods of producing the porous ?-TCP material and inducing bone formation are also provided.

Abstract: The invention relates to a wound dressing comprising a microbial-derived cellulose for treatment of specific types of chronic wounds, including pressure sores, venous and diabetic ulcers. The wound dressing is capable of donating liquid to dry substrates is also capable of absorbing exudating wounds.

Abstract: The invention relates to a transdermal therapeutic systems with fentanyl or an analogous fentanyl derivative as active ingredient. In order to prevent inadvertent overdosage by uncontrolled release of active ingredient as a result of damage, the active ingredient is contained in fluid-filled micro-reservoirs in the layer containing the active ingredient. The layer containing the active ingredient can optionally be provided with a membrane.

Abstract: The present invention is for novel compositions and methods for treating diseases caused by cellular proliferation, particularly, for treating cancer in mammals and more particularly in humans. The therapeutic compositions of the present invention include SN-38 lipid complexes in which the complexes can contain any of a variety of neutral or charged lipids and, desirably, cardiolipin. The compositions are capable of efficiently incorporating SN-38 into complexes and are capable of solubilizing relatively high concentrations of SN-38.

Abstract: An ondansetron solid orally disintegrating dosage form for oral administration having at least one first water-dispersible component or water-insoluble cellulose derivative, a component having a —CHOH functional group, a disintegrating agent and at least one lubricant is provided. The dosage form can comprise ondansetron, a hydrophilic polymer such as microcrystalline cellulose, a component having a —CHOH functional group such as mannitol or xylitol and a disintegrating agent such as crospovidone. The lubricant may be a mixture of magnesium stearate, sodium stearyl fumarate and colloidal silicon dioxide. The present invention provides a non-effervescent tablet comprising the ondansetron dosage form. Another aspect of the invention is the treatment of emesis such as nausea and vomiting caused by cancer chemotherapy and radiation by the administration of the ondansetron formulation of the present composition.

Abstract: A pharmaceutical composition including therapeutically effective amounts of at least one HMG-CoA reductase inhibitor present as a dyhydroxyacid salt and at least one additional therapeutic agent.

Abstract: The present invention is directed to nanoparticulate compositions comprising topiramate. The topiramate particles of the composition have an effective average particle size of less than about 2 microns.